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Australian Diabetes Obesity and Lifestyle Study 
(AusDiab) 




Australian Diabetes Obesity and Lifestyle Study 
(AusDiab) 




Australian Diabetes Obesity and Lifestyle Study 
(AusDiab) 




North West Adelaide Health Study (NWAHS) Australia 1999-2003 3,979 50.5 (16.4) 47.5% Community Urban FPG, HbA1c Lab Lab 
North West Adelaide Health Study (NWAHS) Australia 2004-2006 3,163 55.1 (15.5) 47.4% Community Urban FPG, HbA1c Lab Lab 
North West Adelaide Health Study (NWAHS) Australia 2008-2010 2,420 57.9 (14.3) 47.1% Community Urban FPG, HbA1c Lab Lab 
The Central America Diabetes Initiative (CAMDI) 
Survey 
Belize 2004-2005 1,306 45.7 (17.4) 38.9% National Both FPG, 2hOGTT Lab - 
Baependi Heart Study Brazil 2010-2013 1,233 44.6 (16.5) 40.6% Community Rural FPG, HbA1c Lab Lab 
China Health and Nutrition Study (CHNS) China 2009 8,496 50.5 (15.0) 47.0% National Both FPG, HbA1c Lab Lab 





1995-1996 2,762 45.9 (12.9) 49.2% National Both FPG, 2hOGTT Lab - 
The Central America Diabetes Initiative (CAMDI) 
Survey 
Costa Rica 2004 974 45.3 (17.1) 32.9% Community Urban FPG, 2hOGTT Lab - 
Costa Rican Longevity and Healthy Aging Study 
(CRELES), Pre-1945 Cohort Wave 1 
Costa Rica 2004-2006 2,587 76.2 (10.2) 45.3% National Both FPG, HbA1c Lab Lab 
Costa Rican Longevity and Healthy Aging Study 
(CRELES), Pre-1945 Cohort Wave 2 
Costa Rica 2006-2008 2,218 77.0 (9.6) 45.5% National Both FPG, HbA1c Lab Lab 
Young Finns Study (YFS), Rural Finland 2011 786 42.0 (4.9) 46.3% National rural FPG, HbA1c Lab Lab 
Young Finns Study (YFS), Urban Finland 2011 1,121 41.9 (5.1) 44.2% National Urban FPG, HbA1c Lab Lab 
The Three City Study (3C Study) France 2008-2010 693 82.3 (4.4) 36.1% Community Urban FPG, HbA1c Lab Lab 




The Central America Diabetes Initiative (CAMDI) 
Survey 
Guatemala 2001-2002 848 40.5 (15.4) 33.6% Community Urban FPG, 2hOGTT Lab - 
The Central America Diabetes Initiative (CAMDI) 
Survey 
Honduras 2003-2004 1,179 40.6 (15.6) 35.5% Community Urban FPG, 2hOGTT Lab - 
New Delhi Birth Cohort, Follow-up Phase 1 India 1999-2002 1,434 28.7 (1.4) 59.0% Community Urban FPG, 2hOGTT Lab - 
New Delhi Birth Cohort, Follow-up Phase 2 India 2006-2009 1,075 35.6 (1.1) 59.5% Community Urban FPG, 2hOGTT Lab - 



























High Prevalence of Diabetes and Cardiovascular Risk 
Factors Associated with Urbanization in India. 
Diabetes Care. 2008;31:893-8. 
India 2006 7,057 38.0 (12.1) 47.0% Community Both FPG, 2hOGTT Lab - 
Bruneck Study Italy 1990 908 58.8 (11.4) 51.1% Community Rural FPG, 2hOGTT Lab - 
Bruneck Study Italy 1995 775 62.6 (11.1) 50.6% Community Rural FPG, 2hOGTT Lab - 
Bruneck Study Italy 2000 692 66.0 (10.3) 47.8% Community Rural FPG, HbA1c Lab Lab 
Bruneck Study Italy 2005 568 69.1 (9.5) 46.3% Community Rural FPG, HbA1c Lab Lab 
Bruneck Study Italy 2010 484 72.5 (8.5) 46.5% Community Rural FPG, HbA1c Lab Lab 
Epidemiological Survey of Kiribati, Rural Kiribati 1981 970 41.7 (15.8) 47.3% Subnational Rural FPG, 2hOGTT Lab - 
Epidemiological Survey of Kiribati, Urban Kiribati 1981 1,720 35.9 (12.4) 50.6% Subnational Urban FPG, 2hOGTT Lab - 




Mauritius Noncommunicable Disease Survey Mauritius 1987 4,960 43.4 (13.2) 46.9% National Both FPG, 2hOGTT Lab - 
Mauritius Noncommunicable Disease Survey Mauritius 1992 6,453 45.6 (12.1) 46.2% National Both FPG, 2hOGTT Lab - 
Mauritius Noncommunicable Disease Survey Mauritius 1998 5,355 48.9 (11.4) 44.3% National Both FPG, 2hOGTT Lab - 
Mauritius Noncommunicable Disease Survey Mauritius 2009 6,080 45.9 (13.6) 45.7% National Both FPG, 2hOGTT Lab - 
Trends in the Prevalence and Incidence of Non-insulin-
dependent Diabetes Mellitus and Impaired Glucose 
Tolerance 
Nauru 1975-1976 425 36.1 (13.5) 48.5% Subnational Both FPG, 2hOGTT Lab - 
Trends in the Prevalence and Incidence of Non-insulin-
dependent Diabetes Mellitus and Impaired Glucose 
Tolerance 
Nauru 1982 1,393 36.5 (13.4) 47.5% National Both FPG, 2hOGTT unknown - 
Trends in the Prevalence and Incidence of Non-insulin-
dependent Diabetes Mellitus and Impaired Glucose 
Tolerance 
Nauru 1987 1,072 39.3 (12.8) 45.3% National Both FPG, 2hOGTT Lab - 
Trends in the Prevalence and Incidence of Non-insulin-
dependent Diabetes Mellitus and Impaired Glucose 
Tolerance 
Nauru 1994 1,364 39.0 (11.3) 47.1% National Both FPG, 2hOGTT Lab - 
The Central America Diabetes Initiative (CAMDI) 
Survey 
Nicaragua 2003-2004 1,552 40.2 (14.8) 46.0% Community Urban FPG, 2hOGTT Lab - 




1996-1998 606 37.9 (12.7) 33.5% Community Rural FPG, 2hOGTT 
Portable for FPG 
 Lab for 2hOGTT 
- 




1996-1998 637 38.6 (12.7) 28.6% Community Urban FPG, 2hOGTT 
Portable for FPG 

























Peru Migrant Study Peru 2007-2008 848 50.6 (10.9) 48.0% Community Both FPG, HbA1c Lab Lab 
CRONICAS Cohort Study Peru 2009-2012 3,114 55.2 (12.7) 48.7% Subnational Both FPG, HbA1c Lab Lab 
Seychelles Heart Survey IV Seychelles 2014 1,212 45.8 (11.1) 43.4% National Both FPG, HbA1c Lab Lab 












2011 5,715 50.2 (16.6) 43.0% National Both FPG, HbA1c Lab Lab 




2012 5,237 50.5 (16.6) 42.1% National Both FPG, HbA1c Lab Lab 
Harmonizing Equation of Risk in Mediterranean 
countries Extremadura (The HERMEX study) 
Spain 2007-2009 2,787 50.8 (14.4) 46.5% Subnational Both FPG, HbA1c Lab Lab 
Study on Nutrition and Cardiovascular Risk in Spain Spain 2008-2010 12,821 47.2 (16.7) 47.4% National Both FPG, HbA1c Lab Lab 
Turkish Adult Risk Factor Study Turkey 2012-2013 425 58.3 (10.1) 48.5% National Both FPG, HbA1c Portable Lab 
The Funafuti Survey Tuvalu 1976 415 38.2 (15.5) 49.4% Subnational Both FPG, 2hOGTT Lab - 
Hertfordshire Cohort Study UK 1999-2004 2,758 65.7 (2.9) 52.5% Subnational Both FPG, 2hOGTT Lab - 
Health Survey for England UK 2003 1,096 57.2 (14.0) 47.8% National Both FPG, HbA1c Lab Lab 
English Longitudinal Study of Ageing, Wave 2 UK 2004-2005 3,701 63.8 (7.4) 46.5% National Both FPG, HbA1c Lab Lab 
English Longitudinal Study of Ageing, Wave 4 UK 2008-2009 4,008 64.1 (7.5) 46.1% National Both FPG, HbA1c Lab Lab 
English Longitudinal Study of Ageing, Wave 6 UK 2012-2013 3,465 65.8 (7.6) 44.0% National Both FPG, HbA1c Lab Lab 
MRC National Survey of Health and Development 
(NSHD) 
UK 2009 1,758 62.0 (0.0) 47.6% National Both FPG, HbA1c Lab Lab 
United States National Health and Nutrition 
Examination Survey (US NHANES) 
USA 1976-1980 3,808 48.8 (16.7) 47.2% National Both FPG, 2hOGTT Lab - 
United States National Health and Nutrition 
Examination Survey (US NHANES) 
USA 1988-1994 3,310 56.7 (11.2) 48.7% National Both FPG, 2hOGTT Lab - 
United States National Health and Nutrition 
Examination Survey (US NHANES) 
USA 1999-2000 1,943 47.6 (19.8) 50.0% National Both FPG, HbA1c Lab Lab 
United States National Health and Nutrition 
Examination Survey (US NHANES) 
USA 2001-2002 2,305 47.2 (20.0) 51.1% National Both FPG, HbA1c Lab Lab 
United States National Health and Nutrition 
Examination Survey (US NHANES) 
USA 2003-2004 2,111 47.9 (20.8) 50.6% National Both FPG, HbA1c Lab Lab 
United States National Health and Nutrition 
Examination Survey (US NHANES) 



























United States National Health and Nutrition 
Examination Survey (US NHANES) 




United States National Health and Nutrition 
Examination Survey (US NHANES) 




United States National Health and Nutrition 
Examination Survey (US NHANES) 













Survey name Country Survey year(s) 
Participants 

















Nutrition and Health of Aging Population in China China 2011 2,241 Community Both FPG, HbA1c Lab Lab 
Kuopio Ischaemic Heart Disease Risk factor Study Finland 1991-1993 517 National Both FPG, 2hOGTT Lab - 
Kuopio Ischaemic Heart Disease Risk factor Study Finland 1998-2001 1,135 National Both FPG, 2hOGTT Lab - 
Kuopio Ischaemic Heart Disease Risk factor Study Finland 2005-2008 1,703 National Both FPG, 2hOGTT Lab - 
National Monitoring of Arterial Risk (MONA LISA) in Lille France 2004-2006 1,378 Community Urban FPG, HbA1c Lab Lab 
National Monitoring of Arterial Risk (MONA LISA) in Bas-
Rhin 
France 2005-2007 1,459 Subnational Both FPG, HbA1c Lab Lab 
Etude Nationale Nutrition Sante France 2006-2007 1,936 National Both FPG, HbA1c Lab Lab 
Enquête Littorale Souffle Air Biologie Environnement 
(ELISABET) Dunkerque 
France 2011-2013 786 Community Urban FPG, HbA1c Lab Lab 
Enquête Littorale Souffle Air Biologie Environnement 
(ELISABET) Lille 
France 2011-2013 1,322 Community Urban FPG, HbA1c Lab Lab 
KORA S4 Study: Kooperative Research in the Region of 
Augsburg Survey 4 




KORA F4 Study: Kooperative Research in the Region of 
Augsburg Follow-Up of Survey 4 




German Health Interview and Examination Survey for Adults 
2008-2011 (DEGS1) 
Germany 2008-2011 5,560 National Both FPG, HbA1c Lab Lab 
Chennai Urban Population Study (CUPS) India 1996-1999 310 Community Urban FPG, 2hOGTT Lab - 
The Hisayama Study Japan 2002-2003 3,212 Community Rural FPG, HbA1c Lab Lab 
National Health and Nutrition Survey Japan 2005 1,360 National Both FPG, HbA1c Lab Lab 
National Health and Nutrition Survey Japan 2006 1,520 National Both FPG, HbA1c Lab Lab 
National Health and Nutrition Survey Japan 2007 1,413 National Both FPG, HbA1c Lab Lab 
National Health and Nutrition Survey Japan 2008 1,618 National Both FPG, HbA1c Lab Lab 
National Health and Nutrition Survey Japan 2009 1,668 National Both FPG, HbA1c Lab Lab 
National Health and Nutrition Survey Japan 2010 1,430 National Both FPG, HbA1c Lab Lab 
Observation des Risques et de la Sante Cardio-Vasculaire au 
Luxembourg (ORISCAV-LUX) 
Luxembourg 2007-2009 1,200 National Both FPG, HbA1c Lab Lab 




Survey name Country Survey year(s) 
Participants 













Life Course Study in Cardiovascular Disease Epidemiology Philippines 2009 623 Subnational Both FPG, 2hOGTT Lab - 
Study of prevalence and control of CVD risk factors in the 
general adult population in Poland (NATPOL) 
Poland 2011 535 National Both FPG, HbA1c Lab Lab 
Singapore Health Study 2012 Singapore 2012-2013 1,712 National Both FPG, HbA1c Lab Lab 
Taiwanese Survey on Hypertension, Hyperglycemia and 
Hyperlipidemia 
Taiwan 2002 6,015 National Both FPG, HbA1c Lab Lab 
Taiwanese Survey on Hypertension, Hyperglycemia and 
Hyperlipidemia 
Taiwan 2007 4,023 National Both FPG, HbA1c Lab Lab 






Webfigure 1: Regional random effects in the regression of diabetes prevalence defined based on HbA1c (HbA1c ≥ 
6.5% or history of diabetes or using insulin or oral hypoglycaemic agents) against diabetes prevalence defined based 
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Webfigure 2: Random effect meta-analysis of diabetes diagnostic sensitivity of HbA1c ≥ 6.5% vs. FPG ≥ 7.0 
mmol/L in previously-undiagnosed participants 
  
Overall  (I-squared = 97.6%, p = 0.000)
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Webfigure 3: Random effect meta-analysis of diabetes diagnostic specificity of HbA1c ≥ 6.5% vs. FPG ≥ 7.0 
mmol/L in previously-undiagnosed participants 
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Webfigure 4: Random effect meta-analysis of diabetes diagnostic sensitivity of HbA1c ≥ 6.5% vs. 2hOGTT ≥ 11.1 
mmol/L in previously-undiagnosed participants 
  
Overall  (I-squared = 97.6%, p = 0.000)
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Webfigure 5: Random effect meta-analysis of diabetes diagnostic specificity of HbA1c ≥ 6.5% vs. 2hOGTT ≥ 11.1 
mmol/L in previously-undiagnosed participants 
  
Overall  (I-squared = 97.3%, p = 0.000)
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Webfigure 6: Random effect meta-analysis of diabetes diagnostic sensitivity of HbA1c ≥ 6.5% vs. FPG ≥ 7.0 
mmol/L  or 2hOGTT ≥ 11.1 mmol/L in previously-undiagnosed participants 
  
Overall  (I-squared = 97.9%, p = 0.000)
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Webfigure 7: Random effect meta-analysis of diabetes diagnostic specificity of HbA1c ≥ 6.5% vs. FPG ≥ 7.0 
mmol/L  or 2hOGTT ≥ 11.1 mmol/L in previously-undiagnosed participants
Overall  (I-squared = 98.0%, p = 0.000)
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Webfigure 8: Random effect meta-analysis of diabetes diagnostic sensitivity of FPG ≥ 7.0 mmol/L vs. 2hOGTT ≥ 
11.1 mmol/L in previously-undiagnosed participants 
Overall  (I-squared = 96.9%, p = 0.000)
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Webfigure 9: Random effect meta-analysis of diabetes diagnostic specificity of FPG ≥ 7.0 mmol/L vs. 2hOGTT ≥ 
11.1 mmol/L in previously-undiagnosed participants 
Overall  (I-squared = 94.4%, p = 0.000)
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